Ozmosi | Carbazochrome sodium sulfonate Drug Profile

Product Description

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous,Oral

FDA Designation: *

Approval Status: Not Approved

Approved Countries: Hong Kong | Indonesia | Taiwan | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Wuzhong Pharmaceutical Group Suzhou Pharmaceutical Factory
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Recent & Upcoming Milestones

Highest Development Phases

Trial	Phase	Trial Status	Disease	Primary Completion Date	Latest Trial Update Date	Data Updated
CTR20240166	N/A	Completed	Purpura	2024-05-02	2025-04-29	Patient Enrollment\|Primary Completion Date\|Start Date\|Study Completion Date\|Treatments\|Trial Status
CTR20223221	N/A	Completed	Intestinal Diseases	2023-04-20	2025-04-29	Patient Enrollment\|Treatments
CTR20232034	N/A	Completed	Intestinal Diseases	2023-04-20	2025-04-29
CTR20230080	N/A	Completed	Intestinal Diseases	2023-02-20	2025-04-29	Patient Enrollment\|Primary Completion Date\|Start Date\|Study Completion Date\|Treatments\|Trial Status
ChiCTR1900020498	N/A	Recruiting	Osteoarthritis\|Osteonecrosis	2019-04-01
ChiCTR1800020094	N/A	Not yet recruiting	Osteonecrosis\|Osteoarthritis	2019-03-14
ChiCTR1800015834	N/A	Recruiting	Osteoarthritis\|Osteonecrosis	2018-09-03
ChiCTR1800015839	N/A	Recruiting	Osteoarthritis	2018-08-13

Recent News Events

Date	Type	Title
05/06/2024	PubMed	Carbazochrome sodium sulfonate and tranexamic acid combination therapy to reduce blood transfusions after 24 h of injury: A retrospective study.
03/05/2024	PubMed	Micelle-mediated chemiluminescence of 6-aza-2-thiothymine-protected gold nanoclusters for carbazochrome sodium sulfonate detection.
01/12/2024	PubMed	Abnormal bleeding after lumbar vertebrae surgery because of acquired factor XIII deficiency: A case report and literature review.
09/14/2023	News Article	The Airport Navaids market size is projected to grow at a 8.1% CAGR until 2030, and this report offers a thorough and comprehensive analysis of the market.
09/14/2023	News Article	Unleashing the Potential of the Foldable Glasses Market the Future Opportunities and Growth Trends growing at a CAGR of 12.9% from 2023 - 2030
09/14/2023	News Article	The Crane Gear Reducer Market size is projected to accelerate at an impressive rate of CAGR of 7% from 2023 to 2030.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions

Carbazochrome sodium sulfonate

Alternative Names: carbazochrome sodium sulfonate Clinical Status: Inactive Latest Update: 2024-05-06 Latest Update Note: PubMed Publication